Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Olukemi Adeyemi"'
Autor:
Tsi Njim, Shabbar Jaffar, Josephine Birungi, Anupam Garrib, Sayoki Mfinanga, Joseph Okebe, Kaushik Ramaiya, Olukemi Adeyemi, Mary Lyons, Kevin Nana, Jean Claude Mbanya
Publikováno v:
BMJ Global Health, Vol 6, Iss 5 (2021)
Background Low-income and middle-income countries are struggling to manage growing numbers of patients with chronic non-communicable diseases (NCDs), while services for patients with HIV infection are well established. There have been calls for integ
Externí odkaz:
https://doaj.org/article/07bae94c376145488708bda4acad998d
Autor:
Anupam Garrib, Tsi Njim, Olukemi Adeyemi, Faith Moyo, Natalie Halloran, Huanyuan Luo, Duolao Wang, Joseph Okebe, Katie Bates, Victor Santana Santos, Kaushik Ramaiya, Shabbar Jaffar
Publikováno v:
Tropical Medicine & International Health. 28:248-261
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::480b743f9529d5f3221e20b148996aeb
https://doi.org/10.1111/tmi.13859
https://doi.org/10.1111/tmi.13859
Autor:
Christopher Stovin, Mark D Russell, Edward Alveyn, Olukemi Adeyemi, Vishit Patel, Maryam A Adas, Fabiola Atzeni, Kenrick K H Ng, Andrew I Rutherford, Sam Norton, Andrew P Cope, James B Galloway
Publikováno v:
Rheumatology. 62
Background/Aims Concerns have been raised about the risk of malignancy with Janus kinase inhibitors (JAKi) following the ORAL Surveillance study, which reported an increased incidence of malignancy with tofacitinib compared with Tumor Necrosis Factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f835d7ba7e8459c04e794570a16eb3ce
https://doi.org/10.1093/rheumatology/kead104.008
https://doi.org/10.1093/rheumatology/kead104.008
Autor:
Mark D Russell, Christopher Stovin, Edward Alveyn, Olukemi Adeyemi, Chun Kit David Chan, Vishit Patel, Maryam A Adas, Fabiola Atzeni, Kenrick K H Ng, Andrew I Rutherford, Sam Norton, Andrew P Cope, James B Galloway
Publikováno v:
Annals of the Rheumatic Diseases. :ard-2023
ObjectivesTo estimate the association of Janus kinase inhibitors (JAKi) with the incidence of malignancy, compared with placebo, tumour necrosis factor (TNF)-α inhibitors (TNFi) and methotrexate.MethodsSystematic searches of databases were performed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24b8850b7abaf48a7b2a2c20e279f13c
https://doi.org/10.1136/ard-2023-224049
https://doi.org/10.1136/ard-2023-224049
Autor:
Kaushik Ramaiya, Olukemi Adeyemi, Mary Lyons, Shabbar Jaffar, Jean Claude Mbanya, Anupam Garrib, Kevin Nana, Tsi Njim, Joseph Okebe, Josephine Birungi, Sayoki Mfinanga
Publikováno v:
BMJ Global Health
BMJ Global Health, Vol 6, Iss 5 (2021)
BMJ Global Health, Vol 6, Iss 5 (2021)
BackgroundLow-income and middle-income countries are struggling to manage growing numbers of patients with chronic non-communicable diseases (NCDs), while services for patients with HIV infection are well established. There have been calls for integr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::276d219ca46c6c2e85060dff146785ce
https://doi.org/10.1136/bmjgh-2020-004669
https://doi.org/10.1136/bmjgh-2020-004669
Autor:
Alex G. Stewart, A. Keenan, Jennifer Atkinson, Andrew D Wonham, Merav Kliner, Olukemi Adeyemi, Evdokia Dardamissis
Publikováno v:
BMJ. 348:g1634-g1634
It seems counterintuitive that in Cesaroni and colleagues’ study larger particles of smoke, dust, and dirt (PM10) were significantly associated with coronary events but smaller toxic organic compounds and heavy metals (PM2.5) were not.1 However, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e53211be2971ff7d07e0b37793266d8
https://doi.org/10.1136/bmj.g1634
https://doi.org/10.1136/bmj.g1634